Home/NexEos Bio/Theresa Mansi
TM

Theresa Mansi

Chief Business Officer

NexEos Bio

NexEos Bio Pipeline

DrugIndicationPhase
NTX-1024Vernal Keratoconjunctivitis (VKC) / Allergic ConjunctivitisPhase 2
NDX-3324Eosinophilic Esophagitis (EoE) - DiagnosticClinical